Redmile Group, LLC Guardant Health, Inc. Transaction History

Redmile Group, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$80.32 - $111.8 $23.9 Million - $33.3 Million	-297,619 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$60.49 - $97.5 $18 Million - $29 Million	297,619 New	297,619 $24.1 Million
Q1 2020 May 15, 2020	SELL	$59.04 - $88.81 $23 Million - $34.6 Million	-389,700 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$59.49 - $82.78 $23.2 Million - $32.3 Million	389,700 New	389,700 $30.5 Million

324

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.64B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Redmile Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Redmile Group, LLC with notifications on news.